Core Viewpoint - Corning Jereh Pharmaceutical-B (09966.HK) has conducted a share buyback on November 17, purchasing 350,000 shares at a total cost of HKD 3.4198 million, indicating a strategic move to enhance shareholder value [1][2]. Group 1: Buyback Details - On November 17, the company repurchased 350,000 shares at prices ranging from HKD 9.640 to HKD 9.860 per share, with a closing price of HKD 9.790 on that day [1]. - The total trading volume for the stock on that day was HKD 15.6234 million [1]. - Year-to-date, the company has completed six buybacks, totaling 2.031 million shares and an aggregate expenditure of HKD 23.3849 million [2]. Group 2: Buyback Summary Table - The buyback details are as follows: - November 17: 350,000 shares at a maximum price of HKD 9.860 and a minimum price of HKD 9.640, costing HKD 3.4198 million - November 7: 560,000 shares at a maximum price of HKD 9.520 and a minimum price of HKD 9.240, costing HKD 5.2610 million - October 28: 320,000 shares at a maximum price of HKD 11.970 and a minimum price of HKD 11.530, costing HKD 3.7684 million - October 16: 400,000 shares at a maximum price of HKD 13.820 and a minimum price of HKD 13.520, costing HKD 5.4830 million - October 14: 293,000 shares at a maximum price of HKD 13.830 and a minimum price of HKD 13.030, costing HKD 3.9669 million - October 13: 108,000 shares at a maximum price of HKD 13.800 and a minimum price of HKD 13.690, costing HKD 1.4860 million [2].
康宁杰瑞制药-B(09966.HK)11月17日回购35.00万股，耗资341.98万港元